167 related articles for article (PubMed ID: 33860360)
1. ASO Author Reflections: Serum Squamous Cell Carcinoma Antigen in Recurrent Esophageal Squamous Cell Carcinoma.
Kanie Y; Okamura A; Watanabe M
Ann Surg Oncol; 2021 Nov; 28(12):7997-7998. PubMed ID: 33860360
[No Abstract] [Full Text] [Related]
2. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
Kanda M; Koike M; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Omae K; Yamada S; Nakayama G; Kodera Y
Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
[TBL] [Abstract][Full Text] [Related]
3. ASO Author Reflections: A Novel Station-Based Nodal Staging System for Esophageal Squamous Cell Carcinoma.
Yuan Y; Hong HG; Chen LQ
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):782-783. PubMed ID: 31605350
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma.
Kumakura Y; Yokobori T; Sohda M; Shirabe K; Kuwano H
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):741-742. PubMed ID: 30315381
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma?
Suzuki T; Okamura A; Watanabe M; Chin K
Ann Surg Oncol; 2020 May; 27(5):1518-1519. PubMed ID: 32108921
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Additional Esophagectomy After Noncurative Endoscopic Resection Versus Upfront Esophagectomy in Patients with T1N0 Esophageal Squamous Cell Carcinoma.
Maruyama S; Okamura A; Watanabe M
Ann Surg Oncol; 2021 Sep; 28(9):4867-4868. PubMed ID: 33492541
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Implementation of Age and Co-morbidity in the Treatment Guideline of Patients with Esophageal Squamous Cell Carcinoma.
Faiz Z; Plukker JTM
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):585-586. PubMed ID: 31011909
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Is Esophagectomy Necessary after Noncurative Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma?
Liu Z; Zhao J; Li Z
Ann Surg Oncol; 2021 Nov; 28(12):7160-7161. PubMed ID: 34263374
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: The Role of Skeletonizing en bloc Esophagectomy in Esophageal Squamous Cell Carcinoma.
Kim DJ; Kim HE
Ann Surg Oncol; 2022 Aug; 29(8):4918-4919. PubMed ID: 35419759
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy.
Deng W; Chen J; Xiao Z
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):802-803. PubMed ID: 31654164
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous Cell Carcinoma.
Baba H; Kanda M; Kodera Y; Fujii T
Ann Surg Oncol; 2020 Sep; 27(9):3257-3258. PubMed ID: 32277319
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Nodal Skip Metastasis Is Associated with Survival Benefit in Thoracic Esophageal Squamous Cell Carcinoma.
Yang YS; Shang QX; Yuan Y; Chen LQ
Ann Surg Oncol; 2021 Oct; 28(11):6353-6354. PubMed ID: 33543386
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Esophageal Squamous Cell Carcinoma-Still a Conundrum.
Squires MH; Salo JC
Ann Surg Oncol; 2022 Feb; 29(2):1334-1335. PubMed ID: 34674090
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma.
Okamura A; Watanabe M; Okui J; Matsuda S; Takemura R; Kawakubo H; Takeuchi H; Muto M; Kakeji Y; Kitagawa Y; Doki Y
Ann Surg Oncol; 2023 Apr; 30(4):2186-2187. PubMed ID: 36538253
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: ANO9 Regulated Cell Cycle in Human Esophageal Squamous Cell Carcinoma.
Katsurahara K; Shiozaki A; Otsuji E
Ann Surg Oncol; 2020 Sep; 27(9):3231-3232. PubMed ID: 32206949
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell Carcinoma.
Yoshida T; Yokobori T; Kuriyama K; Sakai M; Sano A; Ogawa H; Sohda M; Saeki H; Kuwano H; Shirabe K
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):791-792. PubMed ID: 32591954
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: NADPH Oxidase 2 has Potential as a Therapeutic Target for Esophageal Squamous Cell Carcinoma.
Shimizu H; Katsurahara K; Inoue H; Shiozaki A; Otsuji E
Ann Surg Oncol; 2022 Dec; 29(13):8688-8689. PubMed ID: 35986132
[No Abstract] [Full Text] [Related]
18. Author Reflections: Relationship of Systemic Inflammatory Response Indicators at Recurrence to Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma: The Utility of Neutrophil-to-Lymphocyte Ratio.
Takeuchi M; Hoshino S; Kawakubo H; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
Ann Surg Oncol; 2021 Jun; 28(6):3009-3010. PubMed ID: 33651215
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Involvement of Intracellular and Extracellular High-Mobility Group Box-1 in the Progression of Esophageal Squamous Cell Carcinoma.
Matsubara D; Konishi H; Otsuji E
Ann Surg Oncol; 2020 Sep; 27(9):3245-3246. PubMed ID: 32248372
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Appropriate Candidates for Salvage Esophagectomy of Initially Unresectable Locally Advanced T4 Esophageal Squamous Cell Carcinoma.
Booka E; Haneda R; Ishii K; Tsubosa Y
Ann Surg Oncol; 2020 Sep; 27(9):3171-3172. PubMed ID: 32270418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
